Showing results (11-20 of 560) with videos related to
Sort By:
Pageof 56
Drugs|November 24, 2007
Pharmacotherapy for oesophagogastric cancerChristopher Jackson, Naureen Starling, Yu Jo Chua, et al.Therapeutic Advances in Medical Oncology|December 22, 2018
Immunotherapy and pancreatic cancer: unique challenges and potential opportunitiesKate Young, Daniel J Hughes, David Cunningham, et al.Frontiers in Oncology|August 6, 2019
Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination StrategiesOliver Butters, Kate Young, David Cunningham, et al.Critical Reviews in Oncology/Hematology|February 21, 2018
Circulating tumour DNA, a promising biomarker for the management of colorectal cancerShelize Khakoo, Alexandros Georgiou, Marco Gerlinger, et al.Gastroenterology Research and Practice|October 5, 2019
Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal AdenocarcinomaCaroline Y K Fong, Emma Burke, David Cunningham, et al.Future Oncology (London, England)|March 12, 2015
Pancreatic neuroendocrine tumors: a reviewKate Young, Ridhima Iyer, Daniel Morganstein, et al.BMC Cancer|July 10, 2008
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparisonAsma Sultana, Paula Ghaneh, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancerAsma Sultana, Catrin Tudur Smith, David Cunningham, et al.Oncotargets and Therapy|December 10, 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesMichael Davidson, Naureen StarlingWorld Journal of Gastrointestinal Oncology|September 5, 2017
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancerMichael Davidson, Ian Chau, David Cunningham, et al.Pageof 56